A new coronavirus vaccine has been hailed by scientists as a breakthrough after initial trials of the drug were successful.

Developed by Pfizer, the vaccine could be rolled out across the UK by Christmas, with initial results suggesting 90 per cent effectiveness.

But the news has been met with a mixed reaction, with Bucks Free Press readers split as to whether they would get the vaccine or not.

ALSO READ: Further coronavirus deaths in Bucks care homes

Commenting on Facebook, Lorraine Hardy said: “I’m not wanting the vaccine thank you and neither does my family,” while Revel Lynne wrote: “Me and my hubby are saying ‘no thank you’, we will take our chances.”

She added: “We don’t know what the risks are with it, nothing has been proven and its only 90%.”

Steve Guy said he would “definitely have it”, adding: “This is the breakthrough that will return us to a more normal life in 2021.

“Ignore the naysayers – it’s either vaccine or interminable lockdowns. I know which I prefer.”

And Aaron Stewart wrote: “90% is amazingly effective for a vaccine so early in its development. We couldn't wish for better at this stage.”

He added: “This is the best news we've had since the virus took hold. It’s our best way out.”

ALSO READ: New coronavirus hotspots in High Wycombe revealed as cases continue to rise

Emily Danbury said: “There are people more in need of the vaccines than me. So I am happy to wait.

“This virus has caused many things for many people, young old rich or poor. We cannot continue the way we are going.”

The elderly and healthcare workers could be the first in line for the vaccine, with interim guidance suggesting those who suffer the worst outcomes from coronavirus and are at highest risk of death be prioritised.

The experimental vaccine is in the final stages of testing and involves injecting the patient with part of the virus’s genetic code in order to train the immune system.

Two doses are needed three weeks apart and the trials from six countries show that a 90 per cent protection rate has been achieved seven days after the first jab.

Data released about the vaccine does not indicate how long immunity lasts, but suggests protection is achieved 28 days after vaccination.